Demand for urology devices is being driven by growing prevalence of urological diseases and growing awareness about urological conditions among the population. Urology has seen a very conspicuous shift towards less invasive treatment methods. Treatment of prostate cancer is shifting from radical prostatectomy to less intrusive alternatives such as laparoscopic surgery, robotic surgery, high intensity focused ultrasound (HIFU) and brachytherapy. Similarly, urinary stones are being managed by less invasive treatment options such as extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy as compared to percutaneous nephrolithotomy (PCNL) and open surgery. Increasingly more patients with benign prostatic hyperplasia (BPH) are being treated with laser therapy, transurethral microwave thermotherapy (TUMT), transurethral needle ablation (TUNA) as compared to transurethral resection of the prostate (TURP).
Based on the findings of the Urologic Diseases in America (UDA) project, the U.S. population spends approximately $11 billion annually on the treatment and management of urological diseases. Global prevalence of urological conditions such as BPH and urinary incontinence, which are more common in the elderly population, is expected to rise due to the ageing population. Prostate cancer is the fourth most common cancer in the world accounting for around 8% of all new cancer cases excluding non-melanoma skin cancer. Specifically in the U.S., prostate cancer is estimated to account for around 10% of the over 161,000 new cancer cases annually.
Urology has been at the forefront of adopting newer technologies to improve patient outcomes. Technologies such as minimally invasive surgery and robotic surgery have been rapidly adopted after being introduced to the urology specialty. Globally, the growth in the procedures conducted with the da Vinci robotic surgical system is being driven by urology procedures with the number of da Vinci Prostatectomies (dVP) performed outside the U.S. market increasing from 65,000 in 2014 to 92,000 in 2016 (Source: Intuitive Surgical annual report).
Efforts are being undertaken in various countries to improve the awareness about urological diseases among the general population, which is being achieved by promotion of prostate cancer screening and initiatives such as Urology Week being undertaken by the European Association of Urology.
The global urology devices market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the market followed by Europe. In APAC, rapidly ageing population in Japan and rapid economic growth in China and India is expected to create a huge demand for urology devices.
The market is also segmented on the basis of main disease types – BPH, prostate cancer, urinary stones, urinary incontinence and other urological conditions. Product segmentation includes urology endoscopes such as cystoscopes, ureteroscopes and nephroscopes, robotic surgical systems, laser systems, lithotripters, brachytherapy systems, HIFU systems, urodynamic systems and urology consumables.
Key players operating in the global urology devices market include Olympus, Karl Storz, Stryker, Richard Wolf, Intuitive Surgical, Dornier MedTech, Lumenis, Cook Medical, Boston Scientific, CR Bard, HealthTronics, Medtronic and other companies.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.